The story of Sildenafil presents a complex picture for shareholders. While the initial launch generated significant gains, the lapse of its patent opened the door to off-brand versions, dramatically eroding sales. This presents a unique risk for drug manufacturers banking on similar blockbuster medications, suggesting that a careless participation

The story of Viagra, and its more info creator copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in sales , its patent expiration created a deluge of knock-off medications, significantly impacting its dominance. While some businesses may seek to capitalize on male sexual dysfunction, the cu